Phrontline Pharma Raises $60M for Bispecific, Dual ADCs
24 Nov 2025 //
PR NEWSWIRE
Samsung Bioepis Phrontline Partner For ADCs In Solid Tumors
20 Oct 2025 //
BUSINESSWIRE
Phrontline Biopharma Initiates Phase 1 Trial for TJ101
15 Sep 2025 //
PR NEWSWIRE

Market Place
Sourcing Support